Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has results × pegilodecakin × Clear all

Phase

Status

Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 552 Bevacizumab 494 Carboplatin 460 Paclitaxel 458 Cisplatin 406 Gemcitabine 374 pembrolizumab 369 Docetaxel 354 Rituximab 340 Radiotherapy 326 Dexamethasone 299 Doxorubicin 283 Nivolumab 261 Fluorouracil 243 Capecitabine 235 Prednisone 216 Erlotinib Hydrochloride 213 Oxaliplatin 211 Etoposide 210 Cytarabine 198 Lenalidomide 197 Trastuzumab 194 Pemetrexed 192 fludarabine phosphate 183 Leucovorin 181 Vincristine 180 Filgrastim 177 Cetuximab 176 Bortezomib 169 Irinotecan 163

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02923921 2020-10-19

Sequoia

Eli Lilly and Company

Phase 3 Completed

567 enrolled 17 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡